Early preparation and prompt influenza vaccination help protect residents, reduce outbreaks, and support a safer healthcare environment throughout the flu season. Facilities should ensure vaccine ordering, consent collection, staff education, and VIS distribution are in place before vaccine shipments arrive.
Early preparation and prompt influenza vaccination help protect residents, reduce outbreaks, and support a safer healthcare environment throughout the flu season. Facilities should ensure vaccine ordering, consent collection, staff education, and VIS distribution are in place before vaccine shipments arrive.
Read More
As influenza season approaches, facilities should begin planning for resident and staff vaccination programs. Specialty Rx has provided updated influenza vaccine ordering information, vaccine coding references, consent forms, and Vaccine Information Statements (VIS) for the 2026-2027 season. Vaccination remains one of the most effective ways to reduce influenza-related illness, hospitalizations, and complications among long-term care residents.
Why Vaccinate?
Residents of skilled nursing and long-term care facilities are at increased risk for severe influenza complications due to advanced age, chronic medical conditions, and congregate living environments. Annual vaccination helps:
Reduce flu-related hospitalizations
Decrease transmission within facilities
Protect vulnerable residents and healthcare workers
Support infection prevention and quality improvement initiatives
Available Flu Vaccines for 2026-27 with billing details:
How can your nursing team prepare for the season:
✅ Begin vaccination planning early
✅ Provide residents and families with the current Influenza Vaccine Information Statement (VIS) prior to vaccination, using the CDC VIS Library or Immunize.org VIS Repository as appropriate
✅ Verify informed consent documentation
✅ Assess residents before vaccination for severe allergic reactions to vaccine components, prior Guillain-Barré Syndrome (GBS), acute febrile illness, and current immunosuppressive therapy
✅ Follow current guidance for residents with egg allergy: any age-appropriate influenza vaccine may be administered, and additional safety measures are not recommended solely because of egg allergy
✅ Track vaccine lot numbers and expiration dates
✅ Vaccinate staff to reduce facility transmission
✅ Monitor and report adverse events according to facility policy and VAERS guidance
Key Takeaway
Early preparation and prompt influenza vaccination help protect residents, reduce outbreaks, and support a safer healthcare environment throughout the flu season. Facilities should ensure vaccine ordering, consent collection, staff education, and VIS distribution are in place before vaccine shipments arrive.
Early preparation and prompt influenza vaccination help protect residents, reduce outbreaks, and support a safer healthcare environment throughout the flu season. Facilities should ensure vaccine ordering, consent collection, staff education, and VIS distribution are in place before vaccine shipments arrive.
MedMemos: Medications That Need Glucose Monitoring
One of the most common disease states in Long Term Care is Diabetes Mellitus Type 2. We always focus on obtaining glycemic control for these patients. However, often we forget that some of the most common classes of medications used to treat other disease states in diabetic patients, can disrupt the glucose levels. This may require extra monitoring of glucose levels or an adjustment of diabetic medications. Below are five commonly-used medication classes that should be reviewed when prescribing for your diabetic resident:
September 2026
New Oral Covid-19 Option for Nursing Homes – XOCOVA
XOCOVA (ensitrelvir) is a new oral antiviral approved for post-exposure prophylaxis of COVID-19 in adults and adolescents 12 years and older after being in contact with someone who has COVID-19. In nursing home settings, staff should know when it may be used, how it is dosed, and what safety checks are required before administration.
July 2026
Proposed Bill Aims to Increase Oversight of AI-Driven Medicare Advantage Denials
The Protecting Patients from Automated Denials Act would prohibit Medicare Advantage plans from denying covered services solely on the basis of artificial intelligence. Instead, a qualified physician would be required to independently review and approve each denial.